{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:56Z","timestamp":1786979636734,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2005,9,6]],"date-time":"2005-09-06T00:00:00Z","timestamp":1125964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1007\/s00125-005-1931-z","type":"journal-article","created":{"date-parts":[[2005,9,5]],"date-time":"2005-09-05T04:15:47Z","timestamp":1125893747000},"page":"2229-2235","source":"Crossref","is-referenced-by-count":62,"title":["Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study"],"prefix":"10.1007","volume":"48","author":[{"given":"M.","family":"Wallander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bartnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Efendic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hamsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Malmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"\u00d6hrvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Norhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,6]]},"reference":[{"key":"1931_CR1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/diacare.22.2.233","volume":"22","author":"M Coutinho","year":"1999","unstructured":"Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events: a meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233\u2013240","journal-title":"Diabetes Care"},{"key":"1931_CR2","first-page":"1617","volume":"35","author":"The DECODE Study Group","year":"1999","unstructured":"The DECODE Study Group (1999) Glucose tolerance and mortality comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 35:1617\u20131621","journal-title":"Lancet"},{"key":"1931_CR3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2337\/diacare.24.1.39","volume":"24","author":"D Liao","year":"2001","unstructured":"Liao D, Shofer JB, Boyko EJ et al (2001) Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese\u2013Americans with normal fasting glucose. Diabetes Care 24:39\u201344","journal-title":"Diabetes Care"},{"key":"1931_CR4","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0140-6736(02)09089-X","volume":"359","author":"A Norhammar","year":"2002","unstructured":"Norhammar A, Tenerz A, Nilsson G et al (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140\u20132144","journal-title":"Lancet"},{"key":"1931_CR5","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.ehj.2004.09.021","volume":"25","author":"M Bartnik","year":"2004","unstructured":"Bartnik M, Malmberg K, Norhammar A, Tenerz, Ohrvik J, Ryden L (2004) Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 25:1990\u20131997","journal-title":"Eur Heart J"},{"key":"1931_CR6","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1001\/jama.1995.03520470063033","volume":"273","author":"W Pimenta","year":"1995","unstructured":"Pimenta W, Korytkowski M, Mitrakou A et al (1995) Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. JAMA 273:1855\u20131861","journal-title":"JAMA"},{"key":"1931_CR7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199603213341207","volume":"334","author":"KS Polonsky","year":"1996","unstructured":"Polonsky KS, Sturis J, Bell GI (1996) Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus\u2014a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334:777\u2013783","journal-title":"N Engl J Med"},{"key":"1931_CR8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI7231","volume":"104","author":"C Weyer","year":"1999","unstructured":"Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787\u2013794","journal-title":"J Clin Invest"},{"key":"1931_CR9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/diacare.24.1.89","volume":"24","author":"C Weyer","year":"2001","unstructured":"Weyer C, Tataranni PA, Bogardus C, Pratley RE (2001) Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24:89\u201394","journal-title":"Diabetes Care"},{"key":"1931_CR10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s001250050643","volume":"40","author":"SM Haffner","year":"1997","unstructured":"Haffner SM, Miettinen H, Stern MP (1997) Are risk factors for conversion to NIDDM similar in high and low risk populations? Diabetologia 40:62\u201366","journal-title":"Diabetologia"},{"key":"1931_CR11","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00125-004-1454-z","volume":"47","author":"IF Godsland","year":"2004","unstructured":"Godsland IF, Jeffs JA, Johnston DG (2004) Loss of beta-cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157\u20131166","journal-title":"Diabetologia"},{"key":"1931_CR12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KGMM Alberti","year":"1998","unstructured":"Alberti KGMM, Zimmet P, for the WHO consultation (1998) Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus\u2014provisional report of a WHO consultation. Diabet Med 15:539\u2013553","journal-title":"Diabet Med"},{"key":"1931_CR13","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/euhj.2000.2305","volume":"21","author":"Anon","year":"2000","unstructured":"Anon (2000) Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21:1502\u20131513","journal-title":"Eur Heart J"},{"key":"1931_CR14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2796.2004.01371.x","volume":"256","author":"M Bartnik","year":"2004","unstructured":"Bartnik M, Malmberg K, Hamsten A et al (2004) Abnormal glucose tolerance\u2014a common risk factor in patients with acute myocardial infarction in comparison with population-based controls. J Intern Med 256:288\u2013297","journal-title":"J Intern Med"},{"key":"1931_CR15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"1931_CR16","volume-title":"Handbook of mathematical functions","author":"M Abramowitz","year":"1972","unstructured":"Abramowitz M, Stegun IA (1972) Handbook of mathematical functions. Dover, New York"},{"key":"1931_CR17","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.ehj.2004.07.027","volume":"25","author":"M Bartnik","year":"2004","unstructured":"Bartnik M, Ryden L, Ferrari R, et al on behalf of the Euro Heart Survey Investigators (2004) The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 25:1880\u20131890","journal-title":"Eur Heart J"},{"key":"1931_CR18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/jc.2004-1795","volume":"90","author":"KM Choi","year":"2005","unstructured":"Choi KM, Lee KW, Kim SG et al (2005) Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus. J Clin Endocrinol Metab 90:175\u2013180","journal-title":"J Clin Endocrinol Metab"},{"key":"1931_CR19","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2337\/diacare.28.5.1182","volume":"28","author":"K Hashimoto","year":"2005","unstructured":"Hashimoto K, Ikewaki K, Yagi H et al (2005) Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes. Diabetes Care 28:1182\u20131186","journal-title":"Diabetes Care"},{"key":"1931_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","volume":"23","author":"M Stumvoll","year":"2000","unstructured":"Stumvoll M, Mitrakou A, Pimenta W et al (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295\u2013301","journal-title":"Diabetes Care"},{"key":"1931_CR21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.24.3.539","volume":"24","author":"A Mari","year":"2001","unstructured":"Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539\u2013548","journal-title":"Diabetes Care"},{"key":"1931_CR22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00125-005-1683-9","volume":"48","author":"A Mari","year":"2005","unstructured":"Mari A, Pacini G, Brazzale AR, Ahren B (2005) Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test. Diabetologia 48:748\u2013751","journal-title":"Diabetologia"},{"key":"1931_CR23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","volume":"44","author":"UK Prospective Diabetes Study Group","year":"1995","unstructured":"UK Prospective Diabetes Study Group (1995) UKPDS 16. Overview of 6 years\u2019 therapy of type II diabetes: a progressive disease. Diabetes 44:1249\u20131258","journal-title":"Diabetes"},{"key":"1931_CR24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1047-2797(98)00002-7","volume":"8","author":"G Howard","year":"1998","unstructured":"Howard G, Bergman R, Wagenknecht LE et al (1998) Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the \u2018minimal model\u2019. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Ann Epidemiol 8:358\u2013369","journal-title":"Ann Epidemiol"},{"key":"1931_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.diabres.2003.09.008","volume":"63","author":"WP Pimenta","year":"2004","unstructured":"Pimenta WP, Rudge MVC, Aragon FF, Padovani CR (2004) Pancreatic beta-cell defects in women at risk of type 2 diabetes. Diabetes Res Clin Pract 63:87\u201392","journal-title":"Diabetes Res Clin Pract"},{"key":"1931_CR26","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2337\/diab.44.12.1386","volume":"44","author":"SM Haffner","year":"1995","unstructured":"Haffner SM, Miettinen H, Gaskill SP, Stern MP (1995) Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican\u2013Americans. Diabetes 44:1386\u20131391","journal-title":"Diabetes"},{"key":"1931_CR27","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/diacare.25.10.1737","volume":"25","author":"G Viberti","year":"2002","unstructured":"Viberti, G, Kahn SE, Greene DA et al (2002) A diabetes outcome progression trial (ADOPT). Diabetes Care 25:1737\u20131743","journal-title":"Diabetes Care"},{"key":"1931_CR28","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1007\/s001250051558","volume":"43","author":"D Tripathy","year":"2000","unstructured":"Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L (2000) Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state. Diabetologia 43:1476\u20131483","journal-title":"Diabetologia"},{"key":"1931_CR29","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2337\/diacare.23.9.1439","volume":"23","author":"A Taniguchi","year":"2000","unstructured":"Taniguchi A, Nagasaka S, Fukushima M et al (2000) Assessment of insulin sensitivity and insulin secretion from the oral glucose tolerance test in nonobese Japanese type 2 diabetic patients: comparison with minimal-model approach. Diabetes Care 23:1439\u20131440","journal-title":"Diabetes Care"},{"key":"1931_CR30","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s001250100580","volume":"44","author":"RE Pratley","year":"2001","unstructured":"Pratley RE, Weyer C (2001) The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 44:929\u2013945","journal-title":"Diabetologia"},{"key":"1931_CR31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1210\/jc.2004-1133","volume":"90","author":"E Ferrannini","year":"2005","unstructured":"Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, Defronzo RA (2005) Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90:493\u2013500","journal-title":"J Clin Endocrinol Metab"},{"key":"1931_CR32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/jc.2004-1258","volume":"90","author":"CW Yeckel","year":"2005","unstructured":"Yeckel CW, Taksali SE, Dziura J et al (2005) The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance. J Clin Endocrinol Metab 90:747\u2013754","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl","key":"1931_CR33","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.diabres.2003.11.024","volume":"66","author":"M Fukushima","year":"2004","unstructured":"Fukushima M, Suzuki H, Seino Y (2004) Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract 66(Suppl):S37\u2013S43","journal-title":"Diabetes Res Clin Pract"},{"key":"1931_CR34","first-page":"415","volume":"13","author":"H Yki-Jarvinen","year":"1992","unstructured":"Yki-Jarvinen H (1992) Glucose toxicity. Endocr Rev 13:415\u2013431","journal-title":"Endocr Rev"},{"key":"1931_CR35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1365-2362.32.s3.3.x","volume":"32","author":"G Boden","year":"2002","unstructured":"Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and \u03b2-cell dysfunction. Eur J Clin Invest 32:14\u201323","journal-title":"Eur J Clin Invest"},{"key":"1931_CR36","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s001250051041","volume":"41","author":"G Paolisso","year":"1998","unstructured":"Paolisso G, Tagliamonte MR, Rizzo MR et al (1998) Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes. Diabetologia 41:1127\u20131132","journal-title":"Diabetologia"},{"key":"1931_CR37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/dmr.5610080206","volume":"8","author":"W Creutzfeldt","year":"1992","unstructured":"Creutzfeldt W, Nauck M (1992) Gut hormones and diabetes mellitus. Diabetes Metab Rev 8:149\u2013177","journal-title":"Diabetes Metab Rev"},{"key":"1931_CR38","first-page":"604","volume":"83","author":"ME Roder","year":"1998","unstructured":"Roder ME, Porte D Jr, Schwartz RS, Kahn SE (1998) Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:604\u2013608","journal-title":"J Clin Endocrinol Metab"},{"key":"1931_CR39","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/diabetes.51.4.1263","volume":"51","author":"AJ Hanley","year":"2002","unstructured":"Hanley AJ, D\u2019Agostino R Jr, Wagenknecht LE et al (2002) Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study. Diabetes 51:1263\u20131270","journal-title":"Diabetes"},{"key":"1931_CR40","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.CIR.0000015855.04844.E7","volume":"105","author":"B Zethelius","year":"2002","unstructured":"Zethelius B, Byberg L, Hales CN, Lithell H, Berne C (2002) Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study. Circulation 105:2153\u20132158","journal-title":"Circulation"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-005-1931-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-005-1931-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-005-1931-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:45:47Z","timestamp":1558597547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-005-1931-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,6]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["1931"],"URL":"https:\/\/doi.org\/10.1007\/s00125-005-1931-z","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,6]]}}}